Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents

•The continuous development of new oncological treatments have led to the emergence of new neurological side effects.•The neurological side effects of oncological treatments can be life threatening or can impair greatly the quality of life; their management should be performed by specialized teams.•...

Full description

Saved in:

Bibliographic Details
Published in:	Revue neurologique Vol. 179; no. 5; pp. 405 - 416
Main Authors:	Bompaire, F., Birzu, C., Bihan, K., Desestret, V., Fargeot, G., Farina, A., Joubert, B., Leclercq, D., Nichelli, L., Picca, A., Tafani, C., Weiss, N., Psimaras, D., Ricard, D.
Format:	Journal Article
Language:	English
Published:	France Elsevier Masson SAS 01.06.2023 Elsevier Masson
Subjects:	Antineoplastic Agents - adverse effects Chemotherapy induced polyneuropathy Humans Immune cell effector associated toxicity Immune checkpoint inhibitors Immunotherapy - adverse effects Immunotherapy - methods Life Sciences Myositis Neoplasms - complications Neoplasms - drug therapy Neurotoxicity Syndromes - diagnosis Neurotoxicity Syndromes - etiology Neurotoxicity Syndromes - therapy Radiation induced leukoencephalopathy Radionecrosis Risk Factors RT Radionecrosis CNS HGG Immune checkpoint inhibitors PRN ICI Immune cell effector associated toxicity PNS RIL PRES PD-L1 Myositis CTLA4 Chemotherapy induced polyneuropathy PD-1 Radiation induced leukoencephalopathy NCS
ISSN:	0035-3787
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!